Following the latest in microcap news, articles, interviews, and more

Pharmaceuticals & Biotech

Cellceutix Invites All to Attend Its Live Webcast of Company’s Presentation at Biotech Showcase 2016

BEVERLY, MA–(Marketwired – January 05, 2016) – Cellceutix Corporation (OTC: CTIX) (the “Company”), a clinical stage biopharmaceutical company developing innovative therapies with oncology, dermatology, anti-inflammatory and antibiotic applications, today announces that the Company will be presenting a corporate overview at the Biotech Showcase™ 2016 investor and networking conference. The upcoming event is being held January […]

CannaVest Corp. Acquires CanX, Inc. and Its Subsidiary Canabine, LLC; Announces Name Change and Appointment of New Director

LAS VEGAS, NV–(Marketwired – January 04, 2016) – CannaVest Corp. (OTCQB: CANV) (the “Company”, “CannaVest”, “our” or “we”) today announced that it has acquired CanX, Inc. and its wholly-owned subsidiary, Canabine, LLC. CanX and Canabine have commenced efforts to develop synthetically-formulated cannabidiol for use in drug development activities, and particularly to pursue approval of the […]

Lixte Biotechnology Holdings, Inc. Announces Exclusive Licensing Of Their Lead Anti-Cancer Compound LB-100 For Potential Treatment Of Hepatocellular Carcinoma In Asia To Taipei Medical University

EAST SETAUKET, N.Y., Jan. 5, 2016 /PRNewswire/ — Lixte Biotechnology Holdings, Inc. (OTCQB: LIXT) announced last week that it has granted an exclusive license of its lead anti-cancer compound, LB-100, for treatment of hepatocellular carcinoma (HCC) in Asia to Taipei Medical University (TMU). LB-100 is not currently approved for treatment of HCC. Under the license, […]

Copyright © EquityBuzz 2016